From: RLIP76, a non-ABC transporter, and drug resistance in epilepsy
ID | Age | Sex | Notes | AED failed | Use |
---|---|---|---|---|---|
1 | 0.8 | M | EPi- Hemispherectomy | None | WB |
2 | 0.3 | M | Epi-Hemispherectomy | Ketogenic Diet | WB, AED transport studies |
3 | 57 | F | Temporal Lobe Epilepsy | PHE, CBZ,TPM | WB |
4 | 33 | F | Control (AVM) | None | WB |
5 | 61 | F | Temporal Lobe epilepsy | VAL,CBZ,TPB | WB, AED transport studies |
6 | 30 | M | Control Parasaggital Cist | None | WB, AED transport studies |
7 | 0.9 | F | Frontal/Parietal Epilepsy | VAL, PBT, TPM | WB |
8 | 14 | M | Temporal Lobe Epilepsy | CBZ, Keppra, PBT,TPM, VAL | WB |
9 | 42 | M | Temporal Lobe Epilepsy | VAL, PBT, primidone, tiagabine, | AED transport studies |
10 | 27 | F | Temporal Lobe Epilepsy | PHE,VAL,gabapentin,CBZ, TPM | AED transport studies |
11 | 7 | M | R. Lateral Parietal/Occipital/Temporal Lobes | PBT, PHE, TPM, CBZ, DZP, LMT | AED transport studies |
12 | 14 | M | Temporal Lobe Epilepsy | VAL,Keppra, CBZ, other | AED transport studies |
13 | 31 | F | Temporal Lobe Epilepsy | gabapentin, CBZ,VAL,PHE,PBT | AED transport studies |
14 | 60 | F | Temporal Lobe Epilepsy | PBT, MBL, TGL, DPT, VLM, MSL, FBT | In vitro cells AED |
15 | 43 | F | Focal Epi | N/A | In vitro cells AED |
16 | 56 | M | Focal Epi | PHE, PBT, CBZ, VAL, ETS | In vitro cells AED |
17 | 43 | F | Temporal Lobe Epilepsy | PHE, CBZ, VAL, GBP | mRNA analysis |
18 | 40 | F | Control (Aneurysm) | NONE | mRNA analysis |
20 | 58 | F | Focal Epi | PHE, PBT, VAL, PRM, FBT, GBP, TPM | mRNA analysis |
21 | 35 | M | Temporal Lobe Epilepsy | PHE, CBZ, VAL, PRM, VGB | mRNA analysis |
22 | 28 | M | Temporal Lobe Epilepsy | PHE, PBT, CBZ, VAL, TPM, CZP, GBP | mRNA analysis |
23 | 38 | M | Temporal Lobe Epilepsy | PHE, CBZ, VAL, FBM, GBP | mRNA analysis |
24 | 39 | M | Temporal Lobe Epilepsy | PHE, PBT, VAL, PRM, MSD | mRNA analysis |
25 | 31 | M | Temporal Lobe Epilepsy | PHE, PBT, VAL, TPM | mRNA analysis |
26 | 23 | M | Temporal Lobe Epilepsy | PHE, PBT, CBZ, VAL, GBP | mRNA analysis |
27 | 45 | F | Control (Aneurysm) | NONE | mRNA analysis |
28 | 22 | F | Control (Aneurysm) | NONE | mRNA analysis |
36 | 7 | M | Temporal Lobe Epilepsy | PHE, CBZ, VAL, GBP | ICC |
37 | 28 | F | Temporal Lobe Epilepsy | PHE, PBT, CBZ, VAL | ICC |
38 | 7 | M | Temporal Lobe Epilepsy | ? | ICC |
39 | 4 | F | Frontal and Parietal Epilepsy | PHE, CBZ, VAL, PRM, | ICC |
40 | 8 | F | Temporal lobe epilepsy | CBZ, PHE, VAL | ICC |
41 | 24 | M | Control (AVM) | NONE | ICC |
42 | 1 | M | Frontal Epilepsy | CBZ, PHE, VAL | ICC |
43 | 25 | M | Temporal Lobe Epilepsy | Phe CBZ | ICC |
44 | 1 | M | Hemispherectomy | None | ICC |
45 | 23 | F | Contol (AVM) | None | ICC |
46 | 23 | M | Temporal lobe epilepsy | gabapentin, CBZ,VAL,PHE, | ICC |
47 | 23 | M | Control (AVM) | None | ICC |
48 | 7 | M | TSC | ? | ICC |
49 | 3 | F | Epilepsy Right Hemi | ? | ICC |
50 | Â | Â | Autopsy | Â | ICC |
51 | Â | Â | Autopsy | Â | ICC |
52 | Â | Â | Autopsy | Â | ICC |
53 | Â | Â | Autopsy | Â | ICC |
54 | Â | Â | Autopsy | Â | ICC,WB |
55 | Â | Â | Autopsy | Â | ICC,WB |